IMPACT OF OZANIMOD (OZA) ON INTERLEUKIN-17A (IL-17A) LEVELS AND THE ASSOCIATION WITH OZA EFFICACY IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC): RESULTS FROM THE PHASE 3 TRUE NORTH (TN) STUDY

Sarah Harris  1     Rachel Maddux  1     Chun Wu  1     Yanhua Hu  1     AnnKatrin Petersen  1     Severine Vermeire  2    
1 Bristol Myers Squibb, Princeton, United States
2 University of Leuven, Leuven, Belgium

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing